Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors or glutathione depletors via a hydrolyzable amide linker
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 533212
Author(s) Chavain, N.; Davioud-Charvet E.,; Trivelli, X.; Mbeki, L.; Rottmann, M.; Brun, R.; Biot, C.
Author(s) at UniBasel Brun, Reto
Year 2009
Title Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors or glutathione depletors via a hydrolyzable amide linker
Journal Bioorganic & medicinal chemistry : a Tetrahedron publication for the rapid dissemenination of full original research papers and critical reviews on biomolecular chemistry, medicinal chemistry and related disciplines
Volume 17
Number 23
Pages / Article-Number 8048-8059
Keywords Bioorganometallics, Dual drugs, Hemozoin, Glutathione reductase, Mechanism of action
Mesh terms Aminoquinolines, pharmacology; Antimalarials, pharmacology; Enzyme Inhibitors, pharmacology; Ferrous Compounds, pharmacology; Hemin, metabolism; Humans; Magnetic Resonance Spectroscopy; Plasmodium falciparum, growth & development; Prodrugs, pharmacology; Spectrometry, Mass, Electrospray Ionization
Abstract Based on the prodrug concept as well as the combination of two different classes of antimalarial agents, we designed and synthesized two series of ferrocenic antimalarial dual molecules consisting of a ferroquine analogue conjugated with a glutathione reductase inhibitor (or a glutathione depletor) through a cleavable amide bond in order to target two essential pathways in the malarial parasites. The results showed no enhancement of the antimalarial activity of the dual molecules but evidenced a unique mode of action of ferroquine and ferrocenyl analogues distinct of those of chloroquine and nonferrocenic 4-aminoquinoline analogues.
Publisher Elsevier
ISSN/ISBN 0968-0896
edoc-URL http://edoc.unibas.ch/dok/A5843140
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.bmc.2009.10.008
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19864147
ISI-Number WOS:000271521000025
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.365 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024